NTM Multiple in Valuation: Next Twelve Months Explained

The NTM multiple—next twelve months—expresses a company’s valuation as a ratio of its projected earnings, revenue, or cash flow for the coming twelve months. It differs from the LTM multiple (last twelve months), which uses historical results, and from a single fiscal year metric. For fast-moving, growth-stage, or cyclical businesses, NTM multiples reveal value more accurately than trailing results, because they capture expected momentum and reduce the noise of temporary headwinds.

Why NTM Matters More Than LTM for Growth Companies

A company posting strong recent earnings may face a revenue cliff or margin compression ahead. Conversely, a company with weak trailing results may be emerging from a trough or in the early stages of a profitable scaling.

The LTM multiple reflects historic performance. If a software company shipped a major new product three months ago but revenue has not yet ramped, its LTM revenue remains depressed. Using LTM to value the company would radically understate its true earning power. An investor relying on LTM multiples would compare a cheap multiple (12x revenue, say) to peers at 8x, and wrongly conclude the stock is expensive.

The NTM multiple projects forward. If consensus estimates expect the software company’s revenue to grow 40% in the next fiscal year, the NTM denominator reflects that growth. The NTM multiple (say, 8x) then properly aligns with peer growth and conveys that the stock is actually in line with the market.

This is why equity research, investment-grade bond analysts, and private equity advisors almost always cite NTM multiples when discussing active growth companies or turnarounds. It is the forward-looking standard.

Building the NTM Denominator from Quarterly Estimates

In practice, the NTM number is not a single point forecast; it is a rolling window assembled from actual results and forward projections.

Assume today is mid-July 2025. The company’s fiscal year runs January to December.

• Q2 2025 has just closed (actual results known)
• Q3 2025 is in progress (likely 75% complete)
• Q4 2025 is next (estimates available from research)
• Q1 2026 is further ahead (estimates available, but less reliable)

The NTM number would be: Q3 2025 actual + Q4 2025 estimate + Q1 2026 estimate + Q2 2026 estimate = NTM EBITDA (or revenue, or earnings per share).

This construction means the NTM number changes subtly almost every business day, as estimates are revised and quarters flip from estimate to actual. A company might trade at 16x NTM EBITDA on Monday, then 15.8x on Tuesday, not because the stock moved, but because Q3 came in slightly ahead of consensus.

Analyst consensus is the bedrock. FactSet, Bloomberg, and S&P Capital IQ aggregate earnings estimates from sell-side research teams covering the stock. The consensus (often the median, sometimes the mean) becomes the published “NTM estimate” cited in financial media, equity research, and investor decks.

NTM vs. Single-Year Fiscal Multiples

Many public companies report on a calendar-year or fiscal-year cycle. Some report on a July-to-June basis; others on October-to-September. A standard practice is also to cite a company’s “trailing fiscal year” multiple or “next fiscal year” multiple, based on the company’s defined fiscal calendar.

These are simpler but less precise than NTM. A company with a calendar year ending December 31 might trade at 14x FY 2025E (next fiscal year estimate). But on November 15, the “next fiscal year” is only 6 weeks away, and “fiscal year 2026” is already 13 months in the future. The reported multiple conflates a near-term and a distant projection.

NTM strips this ambiguity. It always means the twelve months ahead, regardless of fiscal-year definitions. For rapidly changing companies (those guiding materially up or down), NTM surfaces the current consensus momentum clearly, whereas a static “FY 2026E” multiple might mask a sharp inflection.

NTM is standard in:

• Equity research reports (“The stock trades at a 15% discount to peers on an NTM basis”)
• M&A advisory (Acquisition multiples are often quoted on NTM to level the playing field between targets with different fiscal calendars)
• Index and sector analysis (fund managers compare relative valuations on NTM EBITDA or revenue)
• Credit analysis (bondholders look at leverage multiples—debt-to-ebitda-ratio—on NTM EBITDA to assess covenant headroom)

The Precision Trap: When Consensus Forecasts Go Wrong

A critical limitation of NTM valuation is that it depends on the accuracy of forward estimates. Analyst consensus can be wildly off.

In tech booms, consensus often drifts too optimistic. Analysts extrapolate past growth rates too far forward, underestimate competitive or macroeconomic headwinds, or simply herd. When actual results fall short of consensus NTM forecasts, stocks repriced sharply lower—not because the business changed fundamentally, but because the denominator shrinks (or sideways).

Conversely, in downturns or when a company has lost credibility with the market, consensus estimates can be too conservative, causing stocks to outperform once recovery becomes visible.

The most durable NTM multiples are those paired with analyst conviction. If 20 equity analysts covering a stock all forecast similar revenue growth and margins over the next year, the consensus is “tight,” and the NTM multiple is more reliable. If the range is wide—some forecasting growth, others decline—the consensus is scattered, the NTM estimate is a statistical average masking disagreement, and the multiple is riskier.

Practical Applications: Trading, Valuation, and M&A

Relative valuation: An investor comparing two growth-stage software companies might see Company A trading at 12x NTM revenue and Company B at 15x NTM revenue. If both are growing 30% and have similar margins, Company A appears cheaper. If Company B is growing 50%, the higher multiple is justified.

Entry/exit signals: A fund manager tracking a position may set a rule: “Sell if the stock hits 20x NTM EBITDA.” This anchors discipline. As consensus estimates rise (due to strong quarterly results), the NTM multiple compresses if the stock price holds steady, creating a favorable exit point.

M&A pricing: A buyer seeking to value a target company will ask its investment bank for consensus NTM EBITDA and revenue estimates (from public markets, or if the target is private, built from first principles). The buyer then applies an acquisition multiple to the NTM number—e.g., “We will pay 10x NTM EBITDA”—to arrive at a total offer price.

Credit decisions: A lender deciding whether to extend a covenant-light loan to a growing company might say, “We will lend provided leverage (debt-to-NTM EBITDA) does not exceed 4.5x.” This protects the lender by allowing modest deleveraging as the business grows into the debt.

Cyclical and Seasonal Adjustments

Some industries face strong cyclicality or seasonality. A retailer’s Q4 (October–December, in most cases) might deliver 40% of annual profit. Its Q1 is weak.

Using trailing LTM results inflates or deflates the multiple depending on where in the cycle the company sits. NTM smooths this by building full-year expectations. A retailer whose LTM includes a strong Q4 (pulling the multiple down) but is heading into weak Q1, might show a higher NTM multiple if consensus expects Q4 to repeat.

This is why cyclical stocks (energy, materials, financial services) sometimes trade at very high LTM multiples when profit is depressed (the denominator is small), but lower NTM multiples when consensus expects normalization. Relying on LTM alone would mislead; NTM corrects for the cycle.

See also